Company: PIII
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0001628280-25-015305
Chunk: 322

Company: P3 Health Partners Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 8
Chunk 322
---
ings upon settlement of restricted stock unit awards(103)(16)Repayment of short-term and long-term debt(30,973)— Proceeds from short-term debt1,871 — Net cash provided by financing activities98,771 100,332 Net change in cash and restricted cash3,168 22,477 Cash and restricted cash, beginning of year40,934 18,457 Cash and restricted cash, end of year$44,102 $40,934 

P3 Health Partners Inc. | 2024 Form 10-K | 82

P3 HEALTH PARTNERS INC. and SUBSIDIARIES 

CONSOLIDATED STATEMENTS OF CASH FLOWS (CONTINUED)

(in thousands)

Year Ended December 31,20242023Supplemental disclosures of cash flow information:Cash paid for interest$14,191 $5,813 Cash paid for income taxes$5,477 $567 Supplemental disclosures of non-cash investing and financing information:Operating lease liabilities arising from obtaining new right-of-use assets$617 $7,222 Operating lease liabilities and right-of-use assets reduced due to lease modification or termination$(92)$— Increase in accrued expenses related to debt issuance costs and original issue discount$307 $212 Increase in accounts payable related to private placement offering costs$686 $12 Increase in accounts payable related to at-the-market offering costs$— $19 Increase in accrued expenses related to at-the-market offering costs$— $206 Increase in other receivable related to at-the-market sales proceeds$— $33 Restricted stock unit awards issued in satisfaction of executive transaction bonuses$— $5,000 Remeasurement adjustment to redeemable noncontrolling interest resulting from ownership changes$(22,831)$(117,860)Fair value adjustment to redeemable noncontrolling interest$(20,579)$20,579 Warrants issued in connection with new debt$12,127 $— Reconciliation of cash and restricted cash:Cash$38,816 $36,320 Restricted cash5,286 4,614 Total cash and restricted cash$44,102 $40,934 

See accompanying notes to consolidated financial statements.

P3 Health Partners Inc. | 2024 Form 10-K | 83